Instylla HES

· Instylla, Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Instylla HES, covering 2024-12-16 to 2026-06-29. Get the full timeline:

Most recent: Clinical Trial Results: Instylla HES Hypervascular Tumor Pivotal Study [NA]